Kewaunee Scientific Files 8-K

Ticker: KEQU · Form: 8-K · Filed: Jun 12, 2024 · CIK: 55529

Kewaunee Scientific CORP /De/ 8-K Filing Summary
FieldDetail
CompanyKewaunee Scientific CORP /De/ (KEQU)
Form Type8-K
Filed DateJun 12, 2024
Risk Levellow
Pages1
Reading Time2 min
Key Dollar Amounts$2.50
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, corporate-update

TL;DR

Kewaunee Scientific filed an 8-K on June 12, 2024, with corporate and financial updates.

AI Summary

Kewaunee Scientific Corporation filed an 8-K on June 12, 2024, reporting other events and financial statements. The filing details the company's corporate information, including its incorporation in Delaware and principal executive offices in Statesville, NC.

Why It Matters

This filing provides an update on Kewaunee Scientific Corporation's corporate and financial reporting to the SEC.

Risk Assessment

Risk Level: low — This is a routine corporate filing with no immediate financial or operational disclosures that suggest elevated risk.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

This 8-K filing serves to report 'Other Events' and 'Financial Statements and Exhibits' for Kewaunee Scientific Corporation.

When was this report filed with the SEC?

The report was filed on June 12, 2024.

In which state is Kewaunee Scientific Corporation incorporated?

Kewaunee Scientific Corporation is incorporated in Delaware.

What is the address of Kewaunee Scientific Corporation's principal executive offices?

The principal executive offices are located at 2700 West Front Street, Statesville, NC 28677.

What is the company's IRS Employer Identification Number?

The company's IRS Employer Identification Number is 38-0715562.

Filing Stats: 442 words · 2 min read · ~1 pages · Grade level 12.1 · Accepted 2024-06-12 16:28:44

Key Financial Figures

Filing Documents

01 Other Events

Item 8.01 Other Events On June 12, 2024, Kewaunee Scientific Corporation announced that the Company plans to release results for its fourth quarter and fiscal year ended April 30, 2024 on June 26, 2024. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release of Kewaunee Scientific Corporation dated June 12, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. KEWAUNEE SCIENTIFIC CORPORATION (Registrant) Date: June 12, 2024 By /s/ Donald T. Gardner III Donald T. Gardner III Vice President, Finance Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing